TMD vs. DN, CTX, VPH, and WLLW
Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Delta 9 Cannabis (DN), Crescita Therapeutics (CTX), Valeo Pharma (VPH), and Willow Biosciences (WLLW). These companies are all part of the "medical" sector.
Titan Medical (TSE:TMD) and Delta 9 Cannabis (TSE:DN) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.
Titan Medical has higher earnings, but lower revenue than Delta 9 Cannabis. Delta 9 Cannabis is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
Titan Medical has a beta of 1.98, suggesting that its stock price is 98% more volatile than the S&P 500. Comparatively, Delta 9 Cannabis has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500.
Titan Medical received 78 more outperform votes than Delta 9 Cannabis when rated by MarketBeat users. However, 100.00% of users gave Delta 9 Cannabis an outperform vote while only 86.14% of users gave Titan Medical an outperform vote.
0.4% of Titan Medical shares are held by institutional investors. 0.4% of Titan Medical shares are held by insiders. Comparatively, 16.1% of Delta 9 Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Titan Medical has a net margin of 39.43% compared to Delta 9 Cannabis' net margin of -24.65%. Titan Medical's return on equity of 857.87% beat Delta 9 Cannabis' return on equity.
In the previous week, Delta 9 Cannabis had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for Delta 9 Cannabis and 0 mentions for Titan Medical. Delta 9 Cannabis' average media sentiment score of 0.39 beat Titan Medical's score of 0.00 indicating that Delta 9 Cannabis is being referred to more favorably in the news media.
Summary
Titan Medical beats Delta 9 Cannabis on 10 of the 15 factors compared between the two stocks.
Get Titan Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Titan Medical Competitors List
Related Companies and Tools
